Stock MRK MERCK & CO., INC.
Add to a list

Calendar Merck & Co., Inc.

Equities

MRK

US58933Y1055

Pharmaceuticals

Real-time Estimate Cboe BZX
Other stock markets
 11:58:02 2026-01-21 EST 		5-day change 1st Jan Change
110.90 USD +1.32% Intraday chart for Merck & Co., Inc. -0.12% +5.34%
11:05am Merck partners with global health coalition to develop affordable Ebola vaccine RE
01-20 Global drugmakers rush to boost US presence as tariff threat looms RE

Chart calendar Merck & Co., Inc.

d9a3ada69abee3738c27a6b94d537._GfSCL32URKc5gZcXOk5baNdYN6tx6EBXAjMBdleU4c.tD7nV8STFVP0jUUaPY8PD80lUa3ml5JkKGCddK1vN8CyN7A-zZEEJMuWZQ~92f8cb85f617cbbc832fef8890219d30

Upcoming events on Merck & Co., Inc.

2026-02-03

Q4 2025 Earnings Release

Add to your calendar

Google
Apple
ICS format
2026-02-03

Q4 2025 Earnings Call

Add to your calendar

Google
Apple
ICS format
2026-04-30

Q1 2026 Earnings Release

Add to your calendar

Google
Apple
ICS format
2026-04-30

Q1 2026 Earnings Call

Add to your calendar

Google
Apple
ICS format
2026-08-03

Q2 2026 Earnings Release

Add to your calendar

Google
Apple
ICS format
2026-08-04

Q2 2026 Earnings Call

Add to your calendar

Google
Apple
ICS format
2026-10-29

Q3 2026 Earnings Release

Add to your calendar

Google
Apple
ICS format
2026-10-29

Q3 2026 Earnings Call

Add to your calendar

Google
Apple
ICS format
2027-02-03

Q4 2026 Earnings Release (Projected)

Add to your calendar

Google
Apple
ICS format
2027-04-28

Q1 2027 Earnings Release (Projected)

Add to your calendar

Google
Apple
ICS format
2027-08-02

Q2 2027 Earnings Release (Projected)

Add to your calendar

Google
Apple
ICS format
2027-11-03

Q3 2027 Earnings Release (Projected)

Add to your calendar

Google
Apple
ICS format

Past events on Merck & Co., Inc.

2026-01-12

J.P. Morgan Healthcare Conference

2025-12-14

Ex-dividend day

2025-12-03

Citi Global Healthcare Conference

2025-12-03

Clinical Trials on Alzheimer Disease Conference - Abstract Number P249

2025-12-02

Clinical Trials on Alzheimer Disease Conference - Abstract Number P112

2025-12-02

Evercore Healthcare Conference

2025-12-01

Clinical Trials on Alzheimer Disease Conference - Abstract Number P112

2025-11-20

Jefferies Global Healthcare Conference

2025-11-17

Acquisition of Cidara Therapeutics, Inc. by Merck & Co., Inc. Call

2025-11-10

American Heart Association Meeting - Abstract Number: 4341629

2025-11-09

American Heart Association Meeting

2025-11-09

American Heart Association Meeting - Abstract Number: 4391641

2025-11-09

American Heart Association Meeting - Abstract Number: 4359798

2025-11-08

American Heart Association Meeting - Abstract Number: 4391578

2025-11-08

American Heart Association Meeting - Abstract Number: 4365782

2025-11-08

American Heart Association Meeting - Abstract Number: 4387511

2025-10-30

Q3 2025 Earnings Call

2025-10-30

Q3 2025 Earnings Release

2025-10-18

European AIDS Conference

2025-10-17

European AIDS Conference

Past dividends on Merck & Co., Inc.

2025-12-14

Quarterly 0.85 USD

2025-09-14

Quarterly 0.81 USD

2025-06-15

Quarterly 0.81 USD

2025-03-16

Quarterly 0.81 USD

2024-12-15

Quarterly 0.81 USD

2024-09-15

Quarterly 0.77 USD

2024-06-16

Quarterly 0.77 USD

2024-03-13

Quarterly 0.77 USD

2023-12-13

Quarterly 0.77 USD

2023-09-13

Quarterly 0.73 USD

2023-06-13

Quarterly 0.73 USD

2023-03-13

Quarterly 0.73 USD

2022-12-13

Quarterly 0.73 USD

2022-09-13

Quarterly 0.69 USD

2022-06-13

Quarterly 0.69 USD

2022-03-13

Quarterly 0.69 USD

2021-12-13

Quarterly 0.69 USD

2021-09-13

Quarterly 0.65 USD

2021-06-13

Quarterly 0.65 USD

Annual results

Fiscal PeriodDecember 2022 2023 2024 2025 2026 2027
Net sales
Million USD		Released
Forecast
Spread 		59 283
59 144
0.24%		60 115
59 938
0.3%		64 168
63 997
0.27%
64 835


67 758


71 339

EBITDA
Million USD		Released
Forecast
Spread 		26 431
24 588
7.5%		10 083
9 362
7.71%		27 897
26 650
4.68%
30 126


24 900


33 765

EBIT
Million USD		Released
Forecast
Spread 		22 522
22 363
0.71%		6 211
6 066
2.4%		23 398
23 593
-0.83%
26 771


20 500


30 320

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		16 444
17 389
-5.44%		1 889
2 857
-33.89%		19 936
21 364
-6.68%
22 622


16 778


30 130

Net income
Million USD		Released
Forecast
Spread 		14 519
14 827
-2.07%		365
1 682
-78.3%		17 117
17 500
-2.19%
20 100


14 048


23 266

EPS
USD		Released
Forecast
Spread 		5,71
5,87
-2.73%		0,14
0,56
-75.16%		6,74
7,01
-3.82%
7,81


5,55


9,49

Announcement Date02/02/2301/02/2404/02/25-

Quarterly results

Fiscal PeriodSeptember 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4 2027 Q1 2027 Q2 2027 Q3
Net sales
Million USD		Released
Forecast
Spread 		15 775
15 204
3.75%		16 112
15 844
1.69%		16 657
16 514
0.87%		15 624
15 507
0.76%		15 529
15 331
1.29%		15 806
15 873
-0.42%		17 276
16 978
1.76%
16 195


15 917


16 494


17 905


17 033


16 985


17 730


19 160

EBITDA
Million USD		Released
Forecast
Spread 		7 367
6 562
12.27%		7 177
7 367
-2.57%		5 466
5 999
-8.89%		6 422
7 737
-16.99%		7 722
6 882
12.2%		7 484
7 160
4.52%		8 710
8 313
4.77%
8 014


2 996


7 795


9 213













EBIT
Million USD		Released
Forecast
Spread 		6 383
5 808
9.91%		6 659
6 519
2.14%		4 913
5 046
-2.63%		5 225
5 140
1.66%		6 623
6 533
1.38%		6 365
6 206
2.56%		7 556
7 139
5.84%
6 200


1 975


6 725


7 946


6 241










Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		5 670
5 267
7.66%		6 006
6 023
-0.29%		4 090
4 535
-9.82%		4 170
4 641
-10.15%		5 903
5 880
0.4%		4 999
5 672
-11.86%		6 745
6 465
4.32%
4 438






















Net income
Million USD		Released
Forecast
Spread 		4 762
4 414
7.88%		5 455
4 942
10.38%		3 157
3 419
-7.66%		3 743
3 700
1.16%		5 079
4 983
1.93%		4 427
4 651
-4.81%		5 785
5 155
12.22%
4 274


-1 883


5 924


6 976













EPS
USD		Released
Forecast
Spread 		1,87
1,79
4.45%		2,14
1,93
10.86%		1,24
1,43
-13.39%		1,48
1,49
-0.58%		2,01
1,93
3.97%		1,76
1,84
-4.45%		2,32
2,06
12.85%
1,61






















Announcement Date25/04/2430/07/2431/10/2404/02/2524/04/2529/07/2530/10/25--------

Upcoming sector events for Merck & Co., Inc.

2026-01-21
ALIVUS LIFE SCIENCES LIMITED Stock Alivus Life Sciences Limited

Q3 2026 Earnings Release

Add to your calendar

Google
Apple
ICS format
2026-01-21
TORRENT PHARMACEUTICALS LIMITED Stock Torrent Pharmaceuticals Limited

Q3 2026 Earnings Release (Projected)

Add to your calendar

Google
Apple
ICS format
2026-01-22
LAURUS LABS LIMITED Stock Laurus Labs Limited

Q3 2026 Earnings Release

Add to your calendar

Google
Apple
ICS format
2026-01-22
GRANULES INDIA LIMITED Stock Granules India Limited

Q3 2026 Earnings Release

Add to your calendar

Google
Apple
ICS format
2026-01-27
GLAND PHARMA LIMITED Stock Gland Pharma Limited

Q3 2026 Earnings Release

Add to your calendar

Google
Apple
ICS format
2026-01-27
JCR PHARMACEUTICALS CO., LTD. Stock JCR Pharmaceuticals Co., Ltd.

Q3 2025 Earnings Release

Add to your calendar

Google
Apple
ICS format
2026-01-27
PIRAMAL PHARMA LIMITED Stock Piramal Pharma Limited

Q3 2026 Earnings Release

Add to your calendar

Google
Apple
ICS format
2026-01-27
AARTI DRUGS LIMITED Stock Aarti Drugs Limited

Q3 2026 Earnings Release (Projected)

Add to your calendar

Google
Apple
ICS format
2026-01-28
TEVA PHARMACEUTICAL INDUSTRIES LIMITED Stock Teva Pharmaceutical Industries Limited

Q4 2025 Earnings Release

Add to your calendar

Google
Apple
ICS format
2026-01-28
CHUGAI PHARMACEUTICAL CO., LTD. Stock Chugai Pharmaceutical Co., Ltd.

Q4 2025 Earnings Release

Add to your calendar

Google
Apple
ICS format
More events

Past sector events for Merck & Co., Inc.

Today
JOHNSON & JOHNSON Stock Johnson & Johnson

Q4 2025 Earnings Release

Today
HANALL BIOPHARMA CO., LTD. Stock Hanall Biopharma Co., Ltd.

Q4 2025 Earnings Release (Projected)

Today
DR. REDDY'S LABORATORIES LIMITED Stock Dr. Reddy's Laboratories Limited

Q3 2026 Earnings Release

2026-01-16
J. B. CHEMICALS & PHARMACEUTICALS LIMITED Stock J. B. Chemicals & Pharmaceuticals Limited

Q3 2026 Earnings Release

2026-01-15
SUPRIYA LIFESCIENCE LIMITED Stock Supriya Lifescience Limited

Q3 2026 Earnings Release (Projected)

2026-01-12
LOTUS PHARMACEUTICAL CO., LTD. Stock Lotus Pharmaceutical Co., Ltd.

December 2025 Sales and Revenue Release

2026-01-10
SCINOPHARM TAIWAN, LTD. Stock ScinoPharm Taiwan, Ltd.

December 2025 Sales and Revenue Release

2026-01-09
CALIWAY BIOPHARMACEUTICALS CO., LTD. Stock Caliway Biopharmaceuticals Co., Ltd.

December 2025 Sales and Revenue Release

2026-01-08
BORA PHARMACEUTICALS CO., LTD. Stock Bora Pharmaceuticals Co., LTD.

December 2025 Sales and Revenue Release

2026-01-08
TILRAY BRANDS, INC. Stock Tilray Brands, Inc.

Q2 2026 Earnings Release

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. MRK Stock
  4. Calendar Merck & Co., Inc.

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States
United-States
Canada
Canada

MIDDLE EAST

Saudi Arabia
Saudi Arabia
United Arab Emirates
United Arab Emirates

EUROPE

France
France
Deutschland
Deutschland
Suisse
Suisse
Schweiz
Schweiz
Italia
Italia
Österreich
Österreich
België
België
Nederland
Nederland
España
España
Sverige
Sverige
United Kingdom
United Kingdom

APAC

Australia
Australia
India
India
Hong Kong
Hong Kong
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition